Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Proteostasis Ther (PTI)

Proteostasis Ther (PTI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 57,925
  • Shares Outstanding, K 52,185
  • Annual Sales, $ 5,000 K
  • Annual Income, $ -59,130 K
  • 60-Month Beta 1.13
  • Price/Sales 12.00
  • Price/Cash Flow N/A
  • Price/Book 1.56
Trade PTI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.75
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/19/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.20
  • Number of Estimates 2
  • High Estimate -0.14
  • Low Estimate -0.25
  • Prior Year -0.23
  • Growth Rate Est. (year over year) +13.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9800 +13.27%
on 12/07/20
1.3100 -15.27%
on 12/11/20
+0.0700 (+6.73%)
since 11/20/20
3-Month
0.9384 +18.29%
on 10/30/20
1.3500 -17.78%
on 10/14/20
-0.0400 (-3.48%)
since 09/22/20
52-Week
0.8700 +27.59%
on 03/16/20
2.7200 -59.19%
on 12/26/19
-0.1350 (-10.84%)
since 12/20/19

Most Recent Stories

More News
Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with Proteostasis

Leading institutional investors commit $33.6 million through a common stock private investment in public equity (“PIPE”) led by Fidelity Management & Research Company, LLC and Invus

PTI : 1.1100 (-3.48%)
Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm – MVC, PTI, CGIX, STND

NEW YORK, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

MVC : 9.12 (+2.59%)
CGIX : 4.61 (-2.33%)
STND : 33.00 (+0.06%)
PTI : 1.1100 (-3.48%)
Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm – GLIBA, CBMG, MVC, PTI

NEW YORK, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

GLIBA : 91.73 (-2.57%)
CBMG : 19.75 (unch)
MVC : 9.12 (+2.59%)
PTI : 1.1100 (-3.48%)
SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Investigations; Investors are Encouraged to Contact the Firm – CBMG, MVC, PTI, CGIX

NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

CBMG : 19.75 (unch)
MVC : 9.12 (+2.59%)
CGIX : 4.61 (-2.33%)
PTI : 1.1100 (-3.48%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Investors are Encouraged to Contact the Firm – MVC, WPX, PTI, SBPH

NEW YORK, Nov. 07, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

MVC : 9.12 (+2.59%)
WPX : 9.43 (+5.36%)
SBPH : 4.8400 (unch)
PTI : 1.1100 (-3.48%)
Hercules Capital Reports Third Quarter 2020 Financial Results

Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by...

OSH : 29.85 (+3.36%)
PLTR : 9.91 (+5.20%)
OM : 21.24 (+3.21%)
CDAK : 2.39 (+4.37%)
UBER : 32.47 (+0.71%)
PTI : 1.1100 (-3.48%)
HTGC : 15.79 (+1.81%)
HCXZ : 25.20 (unch)
HCXY : 25.31 (-0.44%)
INVESTIGATION ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm – GLIBA, PTI, MR, CBMG

NEW YORK, NY / ACCESSWIRE / October 17, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: GCI Liberty, Inc. (NASDAQ:GLIBA) concerning potential violations of the federal securities...

GLIBA : 91.73 (-2.57%)
PTI : 1.1100 (-3.48%)
MR : 5.36 (-1.29%)
CBMG : 19.75 (unch)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of NTN, VRTU, CBMG, and PTI Mergers

WILMINGTON, Del., Oct. 09, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

NTN : 5.40 (+1.12%)
VRTU : 51.33 (+0.03%)
CBMG : 19.75 (unch)
PTI : 1.1100 (-3.48%)
IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Is Investigating the Following Companies; Shareholders are Encouraged to Contact the Firm – SBPH, GLIBA, CBMG, PTI

NEW YORK, NY / ACCESSWIRE / September 23, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH) concerning potential violations...

SBPH : 4.8400 (unch)
GLIBA : 91.73 (-2.57%)
CBMG : 19.75 (unch)
PTI : 1.1100 (-3.48%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of SBPH, NTN, PTI and GLIBA Mergers

WILMINGTON, Del., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

SBPH : 4.8400 (unch)
NTN : 5.40 (+1.12%)
PTI : 1.1100 (-3.48%)
GLIBA : 91.73 (-2.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Proteostasis Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics to treat diseases caused by an imbalance in the proteostasis network primarily in the United States. Proteostasis Therapeutics, Inc. is based in Cambridge, Massachusetts....

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 1.2367
1st Resistance Point 1.1733
Last Price 1.1100
1st Support Level 1.0733
2nd Support Level 1.0367
3rd Support Level N/A

See More

52-Week High 2.7200
Fibonacci 61.8% 2.0133
Fibonacci 50% 1.7950
Fibonacci 38.2% 1.5767
Last Price 1.1100
52-Week Low 0.8700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar